4097
We initiated a phase I / II trial to determine the response and toxicity of escalating paclitaxel doses combined with fixed - dose cisplatin with granulocyte colony - stimulating factor support in patients with untreated locally advanced inoperable head and neck carcinoma .
 Disease: toxicity; Chemical: paclitaxel; Chemical: cisplatin; Disease: head and neck carcinoma
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
 Entities: toxicity, paclitaxel, cisplatin, head and neck carcinoma 
Answer:
 Disease: toxicity; Chemical: paclitaxel; Chemical: cisplatin; Disease: head and neck carcinoma